New probes aim to sharpen prostate cancer scans
NCT ID NCT07365397
First seen Jan 27, 2026 · Last updated May 19, 2026 · Updated 13 times
Summary
This study tests three new radioactive imaging agents against the standard one to see which best highlights prostate cancer tumors on PET/CT scans. Nine men with advanced prostate cancer will receive both the standard and new agents so doctors can compare how clearly tumors appear. The goal is to improve detection of cancer spread, not to treat the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.